Reliable epithelial-mesenchymal transition biomarkers for colorectal cancer detection.
Kaitlin A GoettschLing ZhangAmar B SinghPunita DhawanDhundy K BastolaPublished in: Biomarkers in medicine (2022)
Aims: To combat increases in colorectal cancer (CRC) incidence and mortality, biomarkers among differentially expressed genes (DEGs) have been identified to objectively detect cancer. However, DEGs are numerous, and additional parameters may identify more reliable biomarkers. Here, CRC DEGs were filtered into a prioritized list of biomarkers. Materials & methods: Two independent datasets (COAD-READ [n = 698] and GSE50760 [n = 36]) were input alternatively to the recently published data-driven reference method. Results were filtered based on epithelial-mesenchymal transition enrichment (χ-square statistic: 919.05; p = 2.2e-16) to produce 37 potential CRC biomarkers. Results: All 37 genes reliably classified CRC samples and ETV4 , CLDN1 and CA2 together were top-ranked by DDR (accuracy: 89%; F1 score: 0.89). Conclusion: Biological and statistical information were combined to produce a better set of CRC detection biomarkers.
Keyphrases
- epithelial mesenchymal transition
- risk factors
- squamous cell carcinoma
- signaling pathway
- gene expression
- acute lymphoblastic leukemia
- physical activity
- magnetic resonance imaging
- cardiovascular disease
- systematic review
- papillary thyroid
- risk assessment
- climate change
- image quality
- human health
- lymph node metastasis
- squamous cell